Cytogen, a liquid biopsy company based on Circulation Tumor Cell , announced on the 20th that i.. - MK -

217330 Stock  KRW 6,180  640.00  9.38%   
About 62% of Cytogen's investor base is looking to short. The analysis of current outlook of investing in Cytogen suggests that many traders are alarmed regarding Cytogen's prospects. The current market sentiment, together with Cytogen's historical and current headlines, can help investors time the market. In addition, many technical investors use Cytogen stock news signals to limit their universe of possible portfolio assets.
  
Cytogen, a liquid biopsy company based on Circulation Tumor Cell , announced on the 20th that i.. - MK

Read at news.google.com
Google News at Macroaxis
  

Cytogen Fundamental Analysis

We analyze Cytogen's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Cytogen using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Cytogen based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Beta

Beta Comparative Analysis

Cytogen is currently under evaluation in beta category among its peers. Beta is one of the most important measures of equity market volatility. Beta can be thought of as asset elasticity or sensitivity to market. In other words, it is a number that shows the relationship of an equity instrument to the financial market in which this instrument is traded. For example, if Beta of equity is 2, it is expected to significantly outperform market when the market is going up and significantly underperform when the market is going down. Similarly, Beta of 1 indicates that an asset and market will generate similar returns over time.

Cytogen Potential Pair-trading

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Cytogen stock to make a market-neutral strategy. Peer analysis of Cytogen could also be used in its relative valuation, which is a method of valuing Cytogen by comparing valuation metrics with similar companies.

Complementary Tools for Cytogen Stock analysis

When running Cytogen's price analysis, check to measure Cytogen's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cytogen is operating at the current time. Most of Cytogen's value examination focuses on studying past and present price action to predict the probability of Cytogen's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cytogen's price. Additionally, you may evaluate how the addition of Cytogen to your portfolios can decrease your overall portfolio volatility.
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Equity Valuation
Check real value of public entities based on technical and fundamental data
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Content Syndication
Quickly integrate customizable finance content to your own investment portal